Skip to main contentSkip to navigation
Sirius Investors
MindMaze Therapeutics Holding S.A.

MindMaze Therapeutics Holding S.A.

RLFTY
OTCHealthcare

RLFTY Financial Statements & Analysis

Complete financial statements for RLFTY including income statement, balance sheet, and cash flow statement. Analyze RLFTY's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q2 '25TTM Q4 '25ChangeImpact
Revenue12.64M9.06M28.4%
Gross Profit1.32M6.43M387.0%
Operating Income-122.49M-29.40M76.0%
Net Income-63.28M-27.02M57.3%
EPS-1.26-0.5457.3%
EBITDA-27.24M-24.58M9.8%
Gross Margin10.45%71.01%579.8%
Operating Margin-968.70%-324.54%66.5%
Net Income Margin-500.43%-298.32%40.4%
R&D Expenses2.33M6.65M185.0%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q4 '25TTM Q2 '25TTM Q4 '24TTM Q2 '24TTM Q4 '23
Revenue9.06M12.64M14.45M
Gross Profit6.43M1.32M-5.02M
Operating Income-29.40M-122.49M-129.71M
Net Income-27.02M-63.28M-115.30M
EPS-0.54-1.26-2.37
EBITDA-24.58M-27.24M-28.28M
Gross Margin71.01%10.45%-34.72%
Operating Margin-324.54%-968.70%-897.67%
Net Income Margin-298.32%-500.43%-797.92%
R&D Expenses6.65M2.33M2.69M

Our detailed financial analysis helps investors understand RLFTY's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track RLFTY's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into RLFTY's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics